Histogen
Patents, Design & Utilities

Last updated:

List of all Histogen patents 9 in total

Status Patent
Grant
Utility: (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetra- fluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases External link
Filling date: 7 Sep 2025 Issue date: 20 Sep 2022
Application
Utility: CONDITIONED MEDIUM AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS External link
Filling date: 7 Sep 2025 Issue date: 30 Jun 2022
Grant
Utility: Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions External link
Filling date: 7 Sep 2025 Issue date: 15 Mar 2022
Application
Utility: COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION External link
Filling date: 7 Sep 2025 Issue date: 3 Feb 2022
Application
Utility: CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: (S)-3-(2-(4-(BENZYL)-3-OXOPIPERAZIN-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,6-TETRA- FLUOROPHENOXY)PENTANOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS CASPASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES External link
Filling date: 7 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: EXTRACELLULAR VESICLES DERIVED FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS External link
Filling date: 7 Sep 2025 Issue date: 14 May 2020

Showing 1 to 9 of 9 patents.